Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

ClinicalTrials.gov ID: NCT01371721

Public ClinicalTrials.gov record NCT01371721. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6 Month, Open Label, Multi Center, Flexible Dose Extension Study To The B2061014 Study To Evaluate The Safety, Tolerability And Efficacy Of Desvenlafaxine Succinate Sustained Release (Dvs Sr) Tablets In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder

Study identification

NCT ID
NCT01371721
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
269 participants

Conditions and interventions

Interventions

  • DVS SR Drug

Drug

Eligibility (public fields only)

Age range
7 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2012
Primary completion
Sep 30, 2015
Completion
Sep 30, 2015
Last update posted
Feb 7, 2017

2012 – 2015

United States locations

U.S. sites
33
U.S. states
19
U.S. cities
29
Facility City State ZIP Site status
Harmonex Neuroscience Research, Inc. Dothan Alabama 36303
Dedicated Clinical Research Goodyear Arizona 85395
University of Arizona Clinical and Translational Science Center (CATS) Tucson Arizona 85724
University of Arizona College of Medicine Dept of Psychiatry Tucson Arizona 85724
Arkansas Psychiatric Clinic Clinical Research Trials, P.A. Little Rock Arkansas 72211
ATP Clinical Research, Incorporated Costa Mesa California 92626
Behavioral Research Specialists, LLC Glendale California 91206
Synergy Clinical Research Center National City California 91950
Neuropsychiatric Research Center of Orange County Orange California 92868
Pacific Clinical Research Medical Group Orange California 92868
Elite Clinical Trials, Incorporated Wildomar California 92595
Children's Hospital Colorado Aurora Colorado 80045
Amedica Research Institute, Incorporated Hialeah Florida 33013
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801
Kolin Research Group Winter Park Florida 32789-3747
Atlanta Center for Medical Research Atlanta Georgia 30331
Institute for Behavioral Medicine, LLC Smyrna Georgia 30080
Psychiatric Associates Overland Park Kansas 66211
Lake Charles Clinical Trials, Lake Charles Louisiana 70629
Precise Research Centers Flowood Mississippi 39232
St. Charles Psychiatric Associates - Midwest Research Group Saint Charles Missouri 63303
Center for Psychiatry and Behavioral Medicine, Incorporated Las Vegas Nevada 89128
North Star Medical Research, LLC Middleburg Heights Ohio 44130
IPS Research Company Oklahoma City Oklahoma 73103
Cutting Edge Research Group Oklahoma City Oklahoma 73116
Paradigm Research Professionals, LLC Oklahoma City Oklahoma 73118
Summit Research Network (Oregon), Incorporated Portland Oregon 97210
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119
Focus & Balance, LLC San Antonio Texas 78229
Grayline Clinical Drug Trials Witchita Falls Texas 76309
Northwest Clinical Research Center Bellevue Washington 98007
Summit Research Network (Seattle) LLC Seattle Washington 98104
Rogers Center for Research and Training, Incorporated Milwaukee Wisconsin 53227

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01371721, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 7, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01371721 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →